-
Sanofi Announces the Launch of Besudil Mesylate Tablets, the First Innovative Drug of its Kind in the Transplantation Field
According to the official WeChat account of Sanofi China, on November 1st, Sanofi announced that its first ROCK2 inhibitor, Besudil Mesylate Tablets (REZUROCK®), will be commercially launched by ...